JP2001503371A - Ｃｄ８＋細胞の個数を減少させるイプリフラボンの使用 - Google Patents

Ｃｄ８＋細胞の個数を減少させるイプリフラボンの使用

Info

Publication number
JP2001503371A
JP2001503371A JP50646497A JP50646497A JP2001503371A JP 2001503371 A JP2001503371 A JP 2001503371A JP 50646497 A JP50646497 A JP 50646497A JP 50646497 A JP50646497 A JP 50646497A JP 2001503371 A JP2001503371 A JP 2001503371A
Authority
JP
Japan
Prior art keywords
cells
lymphocytes
ipriflavone
liquid carrier
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP50646497A
Other languages
English (en)
Japanese (ja)
Inventor
ベー・コバーチユ，アツテイラ
アラーニ，ペーテル
ケレペシ，テレージア
バーライ，ジユルジイ
タル，アツテイラ
Original Assignee
キノイン・ジヨージセル・エーシユ・ベジエーセテイ・テルメーケク・ジヤーラ・エル・テー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by キノイン・ジヨージセル・エーシユ・ベジエーセテイ・テルメーケク・ジヤーラ・エル・テー filed Critical キノイン・ジヨージセル・エーシユ・ベジエーセテイ・テルメーケク・ジヤーラ・エル・テー
Publication of JP2001503371A publication Critical patent/JP2001503371A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
JP50646497A 1995-07-21 1996-07-16 Ｃｄ８＋細胞の個数を減少させるイプリフラボンの使用 Pending JP2001503371A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
HU9502198 1995-07-21
HU9502198A HU9502198D0 (en) 1995-07-21 1995-07-21 Novel indication
PCT/HU1996/000038 WO1997003664A1 (en) 1995-07-21 1996-07-16 Use of ipriflavone to reduce the number of cd8+ cells

Publications (1)

Publication Number Publication Date
JP2001503371A true JP2001503371A (ja) 2001-03-13

Family

ID=10987063

Family Applications (1)

Application Number Title Priority Date Filing Date
JP50646497A Pending JP2001503371A (ja) 1995-07-21 1996-07-16 Ｃｄ８＋細胞の個数を減少させるイプリフラボンの使用

Country Status (22)

Country Link
EP (1) EP0841915A1 (de)
JP (1) JP2001503371A (de)
KR (1) KR19990028933A (de)
CN (1) CN1191483A (de)
AR (1) AR002905A1 (de)
AU (1) AU6367096A (de)
BG (1) BG102182A (de)
BR (1) BR9610187A (de)
CA (1) CA2227421A1 (de)
CZ (1) CZ2798A3 (de)
EA (1) EA199800146A1 (de)
EE (1) EE9800020A (de)
HR (1) HRP960345A2 (de)
HU (1) HU9502198D0 (de)
IL (1) IL122751A0 (de)
MX (1) MX9800603A (de)
NO (1) NO980127L (de)
PL (1) PL324460A1 (de)
SK (1) SK3298A3 (de)
WO (1) WO1997003664A1 (de)
YU (1) YU42796A (de)
ZA (1) ZA966079B (de)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1241079B (it) * 1990-03-23 1993-12-29 Chiesi Farma Spa Composizioni farmaceutiche contenenti ipriflavone,procedimento per la loro preparazione e relativo impiego terapeutico
HU212932B (en) * 1993-08-02 1996-12-30 Chinoin Gyogyszer Es Vegyeszet Parmaceutical composition containing ipriflavone, hydroxyapatit and tricalciumphosphate for treating lack of bones and process for producing the composition

Also Published As

Publication number Publication date
HRP960345A2 (en) 1998-02-28
IL122751A0 (en) 1998-08-16
EE9800020A (et) 1998-08-17
BG102182A (en) 1998-08-31
NO980127D0 (no) 1998-01-12
EP0841915A1 (de) 1998-05-20
HU9502198D0 (en) 1995-09-28
PL324460A1 (en) 1998-05-25
CZ2798A3 (cs) 1998-06-17
MX9800603A (es) 1998-04-30
KR19990028933A (ko) 1999-04-15
AR002905A1 (es) 1998-04-29
SK3298A3 (en) 1998-07-08
NO980127L (no) 1998-01-12
EA199800146A1 (ru) 1998-08-27
CN1191483A (zh) 1998-08-26
YU42796A (sh) 1999-03-04
WO1997003664A8 (en) 1999-08-05
WO1997003664A1 (en) 1997-02-06
AU6367096A (en) 1997-02-18
CA2227421A1 (en) 1997-02-06
ZA966079B (en) 1998-01-19
BR9610187A (pt) 1998-07-28

Similar Documents

Publication Publication Date Title
JP2562857B2 (ja) 抗マラリア性組成物
JPH11506421A (ja) 腸感染に対する薬物の調製のためのフマギロールおよびその誘導体の使用
EP0344880A2 (de) Pharmazeutische Zusammensetzungen mit krebshemmender Wirkung
JPH10139670A (ja) インターロイキン１２誘導物質及び医薬組成物
CA2300289C (en) A pharmaceutical composition active in reducing production of mcp-1 protein
WO2014178048A1 (en) Cannabidiol for the prevention and treatment of graft-versus-host disease
JP2706371B2 (ja) 癌治療用補助剤及びそれを用いたキット
PL185678B1 (pl) Nowe zastosowanie dimeru lizozymu
JPH08507774A (ja) 手術後の悪心および嘔吐の治療のためのグラニセトロンの使用
US6001828A (en) Use of tumor factor inhibitors together with antiviral agents and therapeutic compositions thereof against HIV infection
JPH07116031B2 (ja) 制癌剤
JP2001503371A (ja) Ｃｄ８＋細胞の個数を減少させるイプリフラボンの使用
US6306901B1 (en) Agent for prophylaxis and therapy of diseases
JPH06135836A (ja) コントラサプレッサー細胞の誘導剤
MXPA98000603A (en) Use of ipriflavona to reduce the number of cells c
HU224715B1 (en) Liposomes containing multiple branch peptide constructions for use against human immunodeficiency virus
IE910973A1 (en) Supportive use of Linomide (R)
JP2999539B2 (ja) 白血球減少症の予防・治療剤
EP0457336A2 (de) Verwendung von Mizoribin zur Behandlung oder Vorbeugung der Multiplen Sklerose
CN114028383A (zh) 一种防治类风湿性关节炎的组合物及应用
JP2000095703A (ja) Ｈｔｌｖ―１関連疾患用経口治療剤及び／又は予防剤
Lang et al. A multicentric, randomized, double-blind, placebo controlled, dose response trial of LF 1695 in cured Hodgkin's desease
Patchen et al. Hemopoietic and survival-enhancing effects of xerosin II, ribavarin, bru-pel, and ampligen
JPH01207235A (ja) 癌細胞転移抑制剤
JPH07309758A (ja) 癌細胞転移阻害剤